CD274 and neoplasm: Interestingly, in three out of the four truly progressing patients (Pt#13, Pt#14, and Pt#16), the strong rise of CD8+ T cells in the tumor microenvironment was matched by an increased expression of the PDL1 inhibitory molecule, thus suggesting an immune escape–associated progression.